World | Business

GlaxoSmithKline Embroiled In Bribery Scandal In China

NPR | July 22, 2013 6:02 p.m.

GlaxoSmithKline officials have admitted that some of the pharmaceutical company’s top executives in China may have violated Chinese laws. Beijing has accused the company of engaging in a wide-ranging bribery scheme to boost sales and profits in the country. The company said it is cooperating with the investigation. Jim Zarroli


blog comments powered by Disqus
Follow on Facebook:
Thanks to our Sponsors:
become a sponsor
Thanks to our Sponsors
become a sponsor